Baumann, Sira M.
Kruse, Natalie J.
Kliem, Paulina S. C.
Amacher, Simon A.
Hunziker, Sabina
Dittrich, Tolga D.
Renetseder, Fabienne
Grzonka, Pascale
Sutter, Raoul http://orcid.org/0000-0002-6575-356X
Article History
Received: 13 September 2023
Accepted: 8 November 2023
First Online: 15 November 2023
Declarations
:
: Not applicable.
: Not applicable.
: SMB reports no disclosures. NJK reports no disclosures. PSCK reports no disclosures. SA is supported by a research grant from the Mach-Gaensslen Foundation Switzerland. SH is supported by the Swiss National Foundation (SNF) (Ref 10001C_192850/1 and 10531C_182422), the Gottfried Julia Bangerter-Rhyner Foundation (8472/HEG-DSV), and the Swiss Society of General Internal Medicine (SSGIM). GMDM was or is supported by the Swiss National Science Foundation. He received travel or consultant honoraria by Bayer, Novartis and BMS/Pfizer, and is paid from a research found at the University Hospital Basel. TDD is supported by the Swiss Heart Foundation, the science funds of the University Hospital Basel, and the Research fund for excellent young researchers of the University of Basel. He holds shares from Johnson&Johnson, Roche, Lilly, Bristol-Myers Squibb, Merck, and Novo Nordisk. FR reports no disclosures. PG reports no disclosures. RS received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Gottfried Julia Bangerter-Rhyner Foundation. He received personal grants from UCB-pharma and holds stocks from Novartis, Roche, Alcon, and Johnson & Johnson.